Takhzyro pi TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age. Hypersensitivity reactions have been observed. What is TAKHZYRO? TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. . See Important Safety information and Allergy information. What is TAKHZYRO? TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. See Important Safety Information and Hypersensitivity Information. Freedom from daily dosing TAKHZYRO is an injection taken under the skin. See information for healthcare professionals about TAKHZYRO, a hereditary angioedema preventive treatment for patients ≥2 years old. Learn about the studies and side effects and talk to your doctor to find out if TAKHZYRO is right for you. kjy6eph n4e kck0fx r1xw 7o qlqod cd0tv0i pceb aocz fmqm0